Cryoport and the Cell and Gene Therapy Catapult have entered into a new strategic partnership to support the advancement of cell and gene therapies. As part of the deal, Cryoport will establish a Good Manufacturing Practice (GMP)-compliant global supply chain logistics centre in the UK at… Read More
A new cooperative network designed to foster collaboration and boost the sharing of knowledge and expertise for the UK’s advanced therapies sector has been launched. The ‘Scottish Advanced Therapy Medicinal Products (ATMP) and Vaccines Network’ specifically targets researchers in the north of the UK… Read More
The Cell and Gene Therapy Catapult (CGT Catapult) has opened its facility in the Edinburgh BioQuarter, its first site in Scotland. By opening these new laboratories, the CGT Catapult aims to provide expertise, resources and technology to help cell therapy developers improve their manufacturing processes and navigate… Read More
